Symmetry Medical to Present at Two Upcoming Investor Conferences
* Reuters is not responsible for the content in this press release.
WARSAW, Ind., Nov. 7, 2011 (GLOBE NEWSWIRE) -- Symmetry Medical Inc. (NYSE:SMA),
a leading global source of innovative medical device solutions, including
surgical instruments, orthopedic implants, and sterilization cases and trays,
announced today that Thomas J. Sullivan, President and Chief Executive Officer
is scheduled to present at two upcoming investor conferences. The first is the
Sidoti & Company Fourth Annual New York Conference in New York City.
Event: Sidoti & Company Fourth Annual New York Conference
Date: Thursday, November 10, 2011
Time: 8:40 a.m. ET
The second conference is the Lazard Capital Markets 8th Annual Healthcare
Conference in New York City.
Event: Lazard Capital Markets 8th Annual Healthcare Conference
Date: Tuesday, November 15, 2011
Time: 9:30 a.m. ET
A live webcast of the presentation at the Lazard conference will be available on
Symmetry Medical's website at www.symmetrymedical.com. A replay of the webcast
will be available for 30 days after the date of the presentation. The
presentation at the Sidoti conference will not be webcast due to Sidoti's
conference policy to not webcast presentations.
About Symmetry Medical Inc.
Symmetry Medical Inc. is a leading global source of innovative medical device
solutions, including surgical instruments, orthopedic implants, and
sterilization cases and trays. The Company's thousands of Teammates provide
design, development and worldwide production capabilities for these products to
customers in the orthopedic industry, other medical device markets, and
specialized non-healthcare markets. Symmetry's trusted reputation and brands,
broad Intellectual Property portfolio and commitment to innovation enable it to
collaborate with hundreds of global medical device manufacturers as well as
thousands of hospitals to provide solutions for today's needs and tomorrow's
growth.
CONTACT: Symmetry Medical Inc.
Fred L. Hite
Senior Vice President
Chief Financial Officer
(574) 371-2218
Investors:
The Ruth Group
Zack Kubow
(646) 536-7020
zkubow@theruthgroup.com
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.


Follow Reuters